From the second half of 2016 to 2018, as a commercial laboratory certified by ISO, we actively participated in public welfare programs in the industry, providing more than 18,000 molecular tests for more than 9,000 patients with chronic myeloid leukemia (CML) free of charge nationwide, and improving the level of standardized testing and treatment of CML across the country, so that patients can benefit from scientific standardized testing.